Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment.

Sleep

Sleep Disorders Unit, Respiratory Department, Reus, Spain ; "Sant Joan" University Hospital, Universitat Rovira i Virgili, IISPV, Reus, Spain.

Published: December 2013

Objective: To evaluate circulating adipocyte and epidermal fatty acid-binding protein (FABP4 and FABP5) concentrations in patients with obstructive sleep apnea (OSA), as well as the effects of continuous positive airway pressure (CPAP) treatment.

Methods: Our cross-sectional study included 125 patients. After polysomnography, 58 participants met the criteria for CPAP treatment and were included in a closed cohort study of 8 weeks of CPAP treatment. General anthropometric and biochemical data and circulating FABP4 and FABP5 levels were determined in all patients at baseline and after CPAP treatment in those receiving this therapy.

Results: Circulating FABP4 but not FABP5 levels were higher in patients with OSA (P = 0.003). FABP4 but not FABP5 values were associated with parameters of OSA severity independently of age, gender, adiposity and insulin resistance (P < 0.05). FABP4 but not FABP5 concentrations were determinants of OSA presence (OR: 1.11, P = 0.010) and severity (OR: 1.06, P = 0.020). After CPAP treatment, FABP4 levels decreased in the more severe patients (P = 0.019), while FABP5 levels increased in all patients (P < 0.001).

Conclusions: FABP4 is directly associated with obstructive sleep apnea severity and did not change with continuous positive airway pressure treatment, while FABP5 was not associated with obstructive sleep apnea severity and increased with continuous positive airway pressure treatment. FABP4 and FABP5 have different associations with obstructive sleep apnea. FABP4 but not FABP5 could be considered a marker of metabolic alterations in obstructive sleep apnea patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825432PMC
http://dx.doi.org/10.5665/sleep.3210DOI Listing

Publication Analysis

Top Keywords

fabp4 fabp5
32
obstructive sleep
20
sleep apnea
20
fabp5 levels
16
cpap treatment
16
circulating fabp4
12
continuous positive
12
positive airway
12
airway pressure
12
fabp5
10

Similar Publications

Expression of fatty acid binding proteins in mesenteric adipose tissue.

Biochem Biophys Res Commun

January 2025

Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota-Twin Cities, Minneapolis, MN, USA; Institute on the Biology of Aging and Metabolism, University of Minnesota-Twin Cities, Minneapolis, MN, USA. Electronic address:

Adipose is a complex tissue comprised of adipocytes, immune cells, endothelial and progenitor stem cells. In humans, there are at least nine defined adipose depots, each containing variable numbers of genetically identified adipocyte clusters suggesting remarkable heterogeneity and potential functionality in each depot with respect to lipid metabolism. Although subcutaneous and visceral depots are commonly analyzed for biochemical and molecular functions, the mesenteric depot has been overlooked yet strongly implicated in lipid mediated immune surveillance.

View Article and Find Full Text PDF

VAMP8 as a biomarker and potential therapeutic target for endothelial cell dysfunction in atherosclerosis.

Gene

January 2025

Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China. Electronic address:

Background: Endothelial cell dysfunction has a critical role in the pathophysiology of atherosclerosis. This study aims to uncover pivotal genes and pathways linked to endothelial cell dysfunction in atherosclerosis, as well as to ascertain the assumed causal effects and potential mechanisms.

Methods: Datasets relevant to endothelial cell dysfunction in atherosclerosis were collected and divided into training and validation sets.

View Article and Find Full Text PDF

Potential safety implications of fatty acid-binding protein inhibition.

Toxicol Appl Pharmacol

October 2024

Artelo Biosciences Limited, Alderley Park, Cheshire SK10 4TG, United Kingdom.

Fatty acid-binding proteins (FABPs) are small intracellular proteins that regulate fatty acid metabolism, transport, and signalling. There are ten known human isoforms, many of which are upregulated and involved in clinical pathologies. As such, FABP inhibition may be beneficial in disease states such as cancer, and those involving the cardiovascular system, metabolism, immunity, and cognition.

View Article and Find Full Text PDF
Article Synopsis
  • - FABPs, or fatty acid-binding proteins, are important for transporting lipids within cells and are involved in various cellular functions like signaling and lipid synthesis.
  • - FABP4, a specific type of FABP found in fat and immune cells, is linked to serious conditions like diabetes and hypertension; elevated levels in patients suggest it could serve as an important disease biomarker.
  • - Recent research has shown increased levels of FABP4 and free fatty acids in the eyes of patients with retinal diseases, hinting at new targets for potential treatments in related conditions.
View Article and Find Full Text PDF

Non-muscle invasive bladder cancers (NMIBC) pTa-pT1 are depicted by a high risk of recurrence and/or progression with an unpredictable clinical evolution. Our aim was to identify, from the original resection specimen, tumors that will progress to better manage patients. We previously showed that A-FABP (Adipocyte- Fatty Acid Binding Protein) loss predicted NMIBC progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!